Global $5.55 Billion Artificial Intelligence (Ai) in Drug Discovery Markets, Analysis & Forecasts, 2017-2021 & 2022-2027 by Application; Therapeutic Area; Offering; Technology; Region – PR Newswire

  • Lauren
  • March 10, 2022
  • Comments Off on Global $5.55 Billion Artificial Intelligence (Ai) in Drug Discovery Markets, Analysis & Forecasts, 2017-2021 & 2022-2027 by Application; Therapeutic Area; Offering; Technology; Region – PR Newswire

DUBLIN, March 10, 2022 /PRNewswire/ — The “Artificial Intelligence in Drug Discovery Market Share, Size, Trends, Industry Analysis Report, By Application; By Therapeutic Area; By Offering; By Technology; By Region; Segment Forecast, 2022 – 2029” report has been added to ResearchAndMarkets.com’s offering.
The global artificial intelligence in drug discovery market size is expected to reach USD 5,558.0 million by 2029Artificial Intelligence (AI) uses complex algorithms and machine learning to acquire significant information from huge datasets. For instance, AI uses RNA sequencing data to recognize genes whose expression correlates with a given cellular condition.
It employs the most recent advancements in biology to create cutting-edge medicine discovery algorithms. The increase in computer processing power, the development of advanced algorithms, and the availability of large datasets are the main drivers that led to the developments in machine learning.Based on application, the global artificial intelligence (AI) in the drug discovery market is clustered into drug optimization & repurposing, preclinical testing, and others. The optimization & repurposing segment accounted for the largest revenue share in the industry as it is economical and demands only Electronic Medical Records (EMR) for medicine repurposing.Based on therapeutic areas, the global market is classified into oncology, neurodegenerative diseases, cardiovascular disease, metabolic diseases, infectious diseases, and others. The oncology segment accounted for the largest revenue share in 2020 as it deals with the diagnosis and prevention of cancer.There are some pharmaceutical companies that are focusing on integrating artificial intelligence with medicine discovery and development. For instance, Pfizer associated with IBM Watson Health, an AI platform, to augment their search for immuno-oncology treatments. Sanofi partnered with Exscientia to discover metabolic-disease therapies.The companies in the industry are engaged in collaborations and expansions with several market platform providers to develop medical treatment.
Key players operating in the global market include

Atomwise
Benevolent AI
Berg Health
BIOAGE
BioSymetrics
Cloud Pharmaceuticals
Cyclica
Deep Genomics
DeepMind
Envisagenics
Euretos
Exscientia
GNS Healthcare
IBM Corporation
Insilico Medicine
Insitro
NuMedii
Numerate
NVIDIA Corporation
OWKIN Inc.
Aria Pharmaceuticals Inc.
Verge Genomics
XtalPi Inc.

Key Topics Covered: 1. Introduction1.1. Report Description1.2. Stakeholders2. Executive Summary2.1. Market Highlights3. Research Methodology3.1. Overview3.1.1. Data Mining3.2. Data Sources3.2.1. Primary Sources3.2.2. Secondary Sources4. Global Artificial Intelligence in Drug Discovery Market Insights4.1. Artificial Intelligence in Drug Discovery – Industry Snapshot4.2. Artificial Intelligence in Drug Discovery Market Dynamics4.2.1. Drivers and Opportunities4.2.1.1. Technological advancements in AI4.2.1.2. Rising industrial partnerships and collaborations4.2.2. Restraints and Challenges4.2.2.1. Inadequate accessibility of data sets4.2.3. Porter’s Five Forces Analysis4.2.4. PESTLE Analysis4.2.5. Artificial Intelligence in Drug Discovery Industry Trends4.2.6. COVID-19 Impact Analysis5. Global Artificial Intelligence in Drug Discovery Market, by Application5.1. Key Findings5.2. Introduction5.2.1. Global Artificial Intelligence in Drug Discovery Market, by Application, 2017 – 2029 (USD Million)5.3. Drug Optimization & Repurposing5.4. Preclinical Testing6. Global Artificial Intelligence in Drug Discovery Market, by Therapeutic Area6.1. Key Findings6.2. Introduction6.2.1. Global Artificial Intelligence in Drug Discovery Market, by Therapeutic Area, 2017 – 2029 (USD Million)6.3. Oncology6.4. Neurodegenerative Diseases6.5. Cardiovascular Disease6.6. Metabolic Diseases6.7. Infectious Disease7. Global Artificial Intelligence in Drug Discovery Market, by Offering7.1. Key Findings7.2. Introduction7.2.1. Global Artificial Intelligence in Drug Discovery Market, by Offering, 2017 – 2029 (USD Million)7.3. Software7.4. Services8. Global Artificial Intelligence in Drug Discovery Market, by Technology8.1. Key Findings8.2. Introduction8.2.1. Global Artificial Intelligence in Drug Discovery Market, by Technology, 2017 – 2029 (USD Million)8.3. Machine Learning8.3.1. Global Artificial Intelligence in Drug Discovery Market, By Machine Learning, By Region, 2017 – 2029 (USD Million)8.3.2. Deep Learning8.3.3. Supervised Learning8.3.4. Reinforcement Learning8.3.5. Unsupervised Learning9. Global Artificial Intelligence in Drug Discovery Market, by Geography9.1. Key findings9.2. Introduction9.2.1. Artificial Intelligence in Drug Discovery Market Assessment, By Geography, 2017 – 2029 (USD Million)10. Competitive Landscape10.1. Expansion and Acquisition Analysis10.2. Partnerships/Collaborations/Agreements/Exhibitions11. Company Profiles11.1. Company Overview11.2. Financial Performance11.3. Product Benchmarking11.4. Recent Developments
For more information about this report visit https://www.researchandmarkets.com/r/69yh1r
Media Contact:
Research and Markets Laura Wood, Senior Manager [email protected] For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716
SOURCE Research and Markets

Source: https://www.prnewswire.com/news-releases/global-5-55-billion-artificial-intelligence-ai-in-drug-discovery-markets-analysis–forecasts-2017-2021–2022-2027-by-application-therapeutic-area-offering-technology-region-301499963.html